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ABSTRACT 
The skin provides a natural physical barrier against particle penetration. Delivery systems design can be used to overcome th ese barrier 
properties of the skin. One long-standing approach for improving topical drug delivery uses penetration enhancers which, penetrate into skin to 
reversibly decrease the barrier resistance. This review focuses on skin penetration pathways, different types of penetration enhancer and the 
technology for topical drug delivery as well as the probable mechanisms of action.  
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Topical drug delivery is the administration of a therapeutic 
agent through intact skin for local and systemic effect. 
Human Skin serves as one of the most easily accessible 
routes of drug administration. However, the presence of 
stratum corneum (SC) on the surface makes it selective 
towards applied drugs or delivery systems. Although, SC has 
been regarded as the major barrier to penetration of 
substances into and through the skin (Paramjit, et al., 2000). 
To move, molecules through the barrier drugs have   to 
overcome a different resistance in each tissue. Transport 
across the skin membrane is obviously a complex 
phenomenon, challenging in analysis .To relate results on 
different penetrants, it is necessary to consider the transfer 
mechanism across skin. Therefore designing of topical 
formulation require specific delivery systems like vesicular 
systems, are the most controversial methods for transdermal 
delivery of active substances (Ijeoma, et.al., 1998). This 
review focuses some delivery systems, uses of the more 
widely investigated physical and chemical penetration 
enhancers with their possible mechanisms of action. This 
review also gives an overview of design of suitable delivery 
system for topical drug delivery. 
PHYSIOLOGY AND ANATOMY OF THE SKIN 
Skin consists of two main layers. The underlying dermis 
contains a variety of cell types, nerves, blood vessels and 
lymphatics embedded in a dense network of connective 
tissue. Above the dermis and separated from it by the 
basement membrane, the epidermis is composed mostly of 
layers of stratified keratinocytes, where the SC cells or 
corneocytes are bathed in a protein rich envelope with an 
outer lipid envelope, surrounded by an extracellular lipid 
matrix (Monteiro., 2010). The skin can also be considered to 
have four distinct layers of tissue.  These are: 
a. Non-viable epidermis (sc) 
b Viable epidermis 
c. Viable dermis 
d. Subcutaneous connective tissue (hypodermis) 
NON-VIABLE EPIDERMIS (SC) 
Sc is the outer most layer of the skin, which is the actual 
physical barrier to most substance that comes in contact 
with the skin. It composed of dead   keratin filled cells known 
as corneocytes with a matrix of intercellular lipids (5-15% ), 
protein (75-85%) which is mainly keratin & water with 10 to 
20 m flat cell layer thick over most of the body(Inayat and 
Mallikarjuna ,2009). 
VIABLE EPIDERMIS 
The structures of the cells in the viable epidermis are physico 
chemically similar to other living tissues. 90% of it is water 
which is resides between the sc and the dermis and has a 
thickness ranging from 50- 100 μm. The density of this 
region is not much different than water.  
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VIABLE DERMIS 
Just beneath the viable epidermis is the dermis. The dermis 
layer is hydrophilic, loose connective tissue composed of 
fibrous protein embedded in an amphorphose ground 
substance. Dermis thickness ranges from 2000 to 3000μm.  
SUBCUTANEOUS CONNECTIVE TISSUE 
The subcutaneous tissue or hypodermis is not actually 
considered a true part of the structured connective tissue .It 
is white, fibrous connective tissue containing blood and 
lymph   vessels, secretory pores of the sweat gland and 
cutaneous nerves (Inayat and Mallikarjuna, 2009) 
THE PERMEATION BARRIER 
Skin as a Barrier  
One of the primary roles of the skin is to act as an effective 
and selective barrier to protect humans from chemical 
exposures (Scheuplein and Blank,1971), (Barr, 2007). In 
particular, the outermost layer of the epidermis, the sc, 
provides a formidable barrier to dermal absorption that 
determines the rate of dermal penetration. A number of 
other factors influence the permeation of chemicals through 
skin, including: lipophilicity, area of contact (site and size), 
duration of exposure, molecular weight, concentration, 
integrity of the sc layer, thickness of the epidermis and the 
mixture in which it is presented (Monte, 2007) 
The Hydrophilic Properties of the Skin  
Hydrophilicity of the skin increase as the depth increases 
from the surface, such that the viable epidermis represented 
by the stratum granulosum, the stratum spinosum and the 
stratum basale, respectively is significantly hydrophilic 
(Forster, et.al, 2009). The dermis layer is also hydrophilic, 
hence favoring the uptake of hydrophilic chemicals.  Active 
transport and facilitated transport processes are absent from 
the sc. This is because the corneocytes are a nucleated and 
keratinized and cannot produce the specialized protein 
structures needed for active or facilitated transport.  So, it is 
commonly assumed that the mechanism of transport through 
the sc is by diffusion (Scheuplein and Blank, 1971). 
The Polarity of the Solute   
It is also considered a major determinant of the partitioning 
pattern observed in the sc. If the solute is highly non-polar, 
the rate of partitioning between the sc and the viable skin 
can be a rate limiting factor due to the more polar nature of 
the deeper layers of the skin (Guy and Hadgraft, 1988). 
Although the sc lipid matrix is the most common route of 
dermal absorption for many chemicals, other routes such as 
hair follicles and sweat glands may also play a role but are 
considered to be negligible.  
Potential Dermal Interaction Sites 
The fate of chemicals exposed to the skin includes 
evaporation from the skin surface, partitioning into the sc 
followed by reversible or irreversible binding, penetration 
into the sc followed by metabolism or penetration to the 
dermis, and absorption into the systemic circulation or 
binding to tissues (Riviere, 2006).  
 
 
Figure.1 Different barriers for drug penetration 
Fig.1 shows different barriers for drug penetration. During 
exposure there is a complex interaction between the drug 
and chemical, the vehicle and the skin, all which may affect 
the partitioning into and diffusion through the skin barrier. 
These interactions may occur simultaneously and may be 
classified according to the physical location of the occurrence 
surface of the skin, sc, epidermis and dermis (Katz, 1973).  
Surface of the Skin 
The most widely studied area of chemical–chemical 
interactions is on the surface of the skin. Factors such as 
altered solubility, precipitation, supersaturation, solvation, 
volatility and physicochemical effects such as altered surface 
tension from the presence of surfactants, changed solution 
viscosity and micelle formation, all contribute to increasing 
the potential of interaction (Barry,  2001).  
Stratum Corneum (SC) 
The SC represents the main physical barrier of the skin, so 
that for a substance permeating across the skin, diffusion 
through the SC is the rate limiting step. Conversely, the SC is 
also the main barrier for diffusion of water out of the skin. 
Interactions between the component like organic vehicles 
and chemicals and the constituents of the sc alter the 
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permeability of the chemical within the intercellular lipids of 
the sc (Rastogi  and Singh, 2001).  
 Epidermis 
One obvious point of potential interaction in the epidermis is 
when a chemical undergoes biotransformation. Induction or 
inhibition of drug metabolizing enzymes or competitive or 
noncompetitive inhibition for occupancy at the enzyme's 
active site may occur with mixture components. Other 
structural and functional enzymes may be affected (e.g. lipid 
synthesis enzymes) which could modify the barrier function 
(Elias, and Feingold, 1992). 
Dermis  
The dermis is the next level for potential interaction. Here, a 
component chemical may directly or indirectly (e.g. via 
cytokine release in the epidermis and dermis) modulate 
vascular uptake of the penetrate (Williams and Riviere,1993) 
which could also affect the depth and extent of chemical 
penetration into underlying tissues.  
Inter-Cellular Spacing 
For most penetrates the intercellular route is favored. Small 
molecules are able to move freely within the intercellular 
spaces and diffusion rates are governed largely by their 
lipophilicity (Watson, et.al2007). 
Tight Junctions 
The existence of functional tight junctions has been 
demonstrated in mammalian stratum granulosum. Although 
many constituent tight  junction proteins have been 
identified in other epithelial layers, as well as follicles 
(Brandner et al.,2003). Tight junctions are regarded as 
important elements of the epidermal barrier system and 
localization and expression of tight junction proteins have 
been shown to be altered in diseases characterized by a 
compromised skin barrier. (Kirschner, et.al, 2009). 
ADVANTAGES OF TOPICAL DRUG DELIVERY  
Topical drug delivery offers the following advantages over 
the oral route.  
 Avoidance of hepatic first pass metabolism.  
 Ability to discontinue administration by removal of the 
system. 
 The ability to control drug delivery for a longer time 
than the usual gastrointestinal transit of oral dosage 
form. 
 The ability to modify the properties of the biological 
barrier to absorption. 
 FACTORS THAT INFLUENCE THE PENETRATION OF 
THE SKIN 
The factors that influence the penetration of the skin barrier 
can be divided into   physiological and physicochemical 
variables. Additional variables are the condition of the skin, 
the skin age, the area of skin treated, the thickness of the skin 
barrier phase, the species variation, and the skin moisture 
content. Skin Condition-“Intactness” of the skin is one of the 
most important factors preventing penetration. Injurious 
agents such as mustard gas, acids, and alkalis injure barrier 
cells and increase permeability. When the sc is damaged, 
diffusive water loss is increased. Complete removal of the 
barrier by stripping enhances the absorption of almost any 
substance in contact with the skin surface. These physical 
and structural differences obviously affect the penetration 
pathways and the penetration resistance of skin (Marzulli, 
et.al.,1969). 
ROUTES FOR SKIN PENETRATION 
The potential interaction between the delivery system, the 
“formula,” and the skin are all of major importance Potential 
routes for skin penetration and the active’s fate upon 
application should all be taken into account throughout 
formulation development (Nava D.2005). The success of a 
dermatological drug to be used for systemic drug delivery 
depends on the ability of the drug to penetrate through skin 
in sufficient quantities to achieve the desired therapeutic 
effect.  There are potentially three distinct routes of 
penetration through the sc, these are intra cellular path way, 
intra follicular pathway and polar path way (Malkinson and 
Rothman, 1961). 
SKIN PENETRATION PATH WAYS 
 
Figure 2.the three main skin penetration path ways 
Intercellular Pathway  
This pathway occurs between the corneocytes, and through 
the intercellular lipids.  It covers 5%–30% of the total 
volume of the stratumcorneum and provides the 
permeability barrier for most molecules. Water has been 
found to penetrate the skin via the intercellular pathway 
(Nava, 2005). 
The Intrafollicular Pathway 
This pathway occurs via penetration through hair follicles. 
Although the available area for diffusion in this pathway is 
approximately 0.1% of the total skin area it is mainly a route 
for very lipophilic molecules and molecules used in 
combination with certain surfactants and   glycols as 
penetration Enhancers.  
The Polar Pathway 
This route is believed to be hydrophilic in nature. It is 
composed of aqueous regions surrounded by polar lipids 
that create the walls of micro channels. It is known to have a 
high penetration resistance to lipophilic compounds but low 
resistance to hydrophilic compounds. It is also thought to be 
the route by which water evaporates through the skin (Daya, 
2005). 
SKIN PENETRATION ENHANCER 
The goal of dermal penetration enhancement is for the 
accelerant to reversibly reduce the barrier resistance of the 
sc without damaging viable cells (Finnin and morgan, 
1999).The method employed for modifying the barrier 
properties of the sc to enhance drug penetration and 
absorption through skin may be classified into four these are 
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chemical, physical, vesicular carrier and Enzymatic  
penetration enhancers. Here only the first three penetration 
enhancers are discussed. 
Ideal characteristics of penetration enhancers  
 They should be non toxic, non irritating and non 
allergenic. 
 They would ideally work rapidly; the activity and 
duration of effect should be both predictable and 
reproducible. 
 They should have no pharmacological activity within 
the body. 
 The penetration enhancers should work 
unidirectionally, i.e., they should allow therapeutic 
agents into the body whilst preventing the loss of  
endogenous materials from the body. 
 When removed from the skin, barrier properties should 
return both rapidly and fully to normal. 
 They should be cosmetically acceptable with an 
appropriate skin feel (Pathan and Mallikarjuna, 2009).  
CHEMICAL ENHANCER 
Chemical substances temporarily diminishing the barrier of 
the skin and known as accelerants or sorption promoters can 
enhance drug flux. These include materials such as azone, 
urea, fatty acids, Dimethylsulphoxide, and Oxazolidinones. 
Azone 
The figure below shows structure of Azone (1-
dodecylazacycloheptan-2-one or laurocapran)  which is the 
first penetration enhancer. It was the first molecule 
specifically designed as a skin penetration enhancer. 
 
Figure 3.Azone, the first molecules synthesized to act as a 
skin penetration enhancer 
Azone is a colourless, odourless liquid with a melting point of 
-7 ºC. Azone is a highly lipophilic material and it is soluble in 
and compatible with most organic solvents including alcohol 
and propylene glycol. Azone enhances the skin transport of a 
wide variety of drugs including steroids, antibiotics and 
antiviral agents. Azone is most effective at low 
concentrations, being employed typically between 0.1- 5% 
but more often between 1- 3% 13. Azone partitions into a 
bilayer lipid to disrupt their packing arrangement but 
integration into the lipid is unlikely to be homogeneous 
(Adrian, and Brian, 2004) 
Urea 
Urea promotes transdermal permeation by facilitating 
hydration of the sc and by the formation of hydrophilic 
diffusion channels within the barrier. Cyclic urea permeation 
enhancers are biodegradable and nontoxic molecules 
consisting of a polar parent moiety and a long chain alkyl 
ester group. As a result, enhancement mechanism may be a 
consequence of both hydrophilic activity and lipid disruption 
mechanism (Singh, and Choudhury,  2007).  
Fatty Acids  
Percutaneous drug absorption has been increased by a wide 
variety of long chain fatty acids, the most popular of which is 
oleic acid. Oleic acid greatly increased the flux of many drugs 
such as increasing the flux of salicylic acid 28 fold and 5-
flurouracil flux 56 fold through human skin membrane. The 
enhancer interacts with and modifies the lipid domains of 
the SC as would be expected for a long chain fatty acid with 
cis configuration (William and Barry, 2004). 
Dimethylsulphoxide  
Dimethylsulphoxide (DMSO) is colourless, odourless, 
hygroscopic penetration enhancers. It is a powerful aprotic 
solvent which hydrogen bonds with itself rather than with 
water; and is often used in many areas of pharmaceutical 
sciences as a ‘‘universal solvent’’. DMSO is used as a co- 
solvent in a vehicle for a commercial preparation. DMSO 
alone has also been applied topically to treat systemic 
inflammation. The penetration enhancing activities of DMSO 
is by promoting both hydrophilic and lipophilic permeants 
and is concentration dependent .generally co-solvents 
containing >60% DMSO are needed for optimum 
enhancement efficacy. However, at these relatively high 
concentrations DMSO can cause erythema and may cause 
some proteins denature. (Kligman, 1965). 
 
 
Figure 4.Dramatic action of enhancers on the integrity of SC. This Figure shows the action of enhancers and how it alters the sc 
integrity. 
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Oxazolidinones 
Oxazolidinones are a new class of chemical agents which 
have the potential for use in many cosmetic and personal 
care product formulations. This is due to their ability to 
localize co administered drug in skin layers, resulting in low 
systemic permeation (Seth B.1999). Oxazolidinones such as 
4-decyloxazolidin-2-one has been reported to localize the 
delivery of many active ingredients such as retinoic acid and 
diclofenac sodium in skin layers. This compound has a 
higher molecular weight and lipophilicity than other solvent 
type enhancers, physical characteristics that may be 
beneficial in terms of a reduction in local toxicity because of 
the lack of effective absorption of these enhancers into the 
lower skin layers where irritation is likely to be occurring.  
(Inayat  and  Mallikarjuna, 2009).      
PHYSICAL ENHANCER 
Although many different physical approaches to enhancing 
percutaneous absorption have been attempted, the most 
notable approaches are Microneedles, sonophoresis 
(ultrasound), Iontophoresis & Electroporation. None of these 
enhancement methods is passive in that they require the 
input of energy to achieve their effects. To date, these 
methods show most promise for TDD systems that 
incorporate a large drug reservoir on the surface of the skin 
(Guy,1996).  
Microneedles 
Standardized micro dimensional needles that are robust 
enough to create pores that reach throughout the entire 
depth of the Sc. Such pores have been observed to facilitate 
the rapid absorption of drugs including even those with 
large molecular weights.  
First Generation Microneedles 
First generation devices were from non-hollow Silicon. 
These micro needles are coated on the outside by the drug 
or active agent. Use of this technology has been shown to 
increase the permeation of calciene (623 Da) by 1,000-fold 
when the micro needles were left embedded in the skin for 
one second, 10,000-fold when removed from the skin after 
being embedded for ten seconds, and 25,000-fold when the 
micro needles were removed from the skin after one hour 
application. Application of these micro needles permitted an 
increase in the permeation of both insulin (5,800 Da) and 
bovine serum albumin (64,000 Da) by more than 10,000-
fold above the sensitivity limit. (Mcallister, et.al., 1999) 
Second Generation Microneedles 
Second generation micro needles are constructed from 
hollow metal or silicon and are filled with drug solution. Use 
of this technology can raise the in vitro permeability of 
calciene, insulin, and bovine serum albumin through human 
skin by more than 100,000 fold above the sensitivity limit. 
Crucially, with this method, creating microscopic pores in 
the skin is not observed to produce any pain. ( Michniak, 
2005) 
Sonophoresis 
Sonophoresis is the use of ultrasound to enhance topical or 
TDD. The technique has been applied for over 40 years by 
physiotherapists in order to treat various arthritic and 
inflammatory conditions. Typically, ultrasound in the 0.5 to 
3 MHz frequency range has been employed for this purpose. 
Very low frequency of ultrasound (i.e., in the 0.02 to 0.1 MHz 
range) can substantially, and reversibly, increase the 
permeability of the Sc. (Terahara, et al.,2002).   This 
enhancement process is a result of the development of 
cavitations, which is the major mechanism of skin 
permeabilization. The cavitations phenomenon is inversely 
related to the frequency of the applied ultrasonic beam 
(Gaertner and Acoust, 1954). Cavitations is the ultrasonically 
induced formation of gaseous cavities. The volumetric 
oscillations and collapse of cavitations bubbles generate 
sufficient disorder in the lipid bilayers of the Sc to 
temporarily permeabilize the membrane. The host of 
parameters including the frequency, intensity, and time of 
application of the applied ultrasonic beam are determine the 
extent of cavitations produced (Gaertner and Acoust, 
1954).Low frequency sonophoresis has been reported to 
facilitate the TDD of proteins like insulin, erythropoietin, and 
gamma interferon in vitro.( Mitragotri et al., 1995 
)Advantage of  sonophoresis is that the skin barrier  function 
is returned to normal levels only several hours after 
sonication is completed 
 Iontophoresis 
This technique is based on the principle that application of 
electric current provides external energy to drug ions for 
passage across the skin, thereby increasing drug 
permeability through the membrane.10A typical 
iontophoretic drug delivery system consists of an anode, a 
cathode and two reservoirs, The movement of ions in 
Iontophoresis follows the basic rule of electricity, i.e. like 
charges repel each other (Priya B.et al 2007). Iontophoretic 
drug delivery occurs by a combination of concentration 
gradient and electrochemical potential gradient developed 
across the skin; increased skin permeability under applied 
electric current and a current induced water transport effect. 
There is an inverse relationship between the molecular 
weight of the permeating molecule and its iontophoretic 
flux.  The delivery rate of a divalent cation was half that of 
the monovalent species. This is attributed to the stronger 
binding of the divalent ion with the fixed negative charges in 
the skin. (Del Terzo, et al.,1989). The Nernst-Planck flux, 
equation mathematically describes iontophoresis. The 
equation indicates that the flux of an ion across a membrane 
under the influence of an electric field is modulated by three 
components: a diffusive component, an iontophoretic 
component, and an electro-osmotic component. The 
equation is symbolically written as ( Michniak, et.al., 2005)
 
      Eq.1     
Where:  
J = molar flux 
C = molar concentration 
u = convective water flow 
D = diffusivity coefficient 
dC/dx  = molar concentration gradient in the 
direction of the low 
z = ionic valence 
E = electric field 
F = Faraday’s constant 
k = Boltzmann constant 
T = temperature (Kelvin) 
 
Nisha Mery Joseph et al                                                                                     Journal of Drug Delivery & Therapeutics. 2018; 8(6):405-420 
ISSN: 2250-1177                                                                                 [410]                                                                                  CODEN (USA): JDDTAO 
 
According to eq.1, the efficiency of drug transport depends 
upon the polarity, valency, and mobility of the charged 
species, as well as upon the electrical duty cycle and 
formulation components selected ( Michniak, et.al., 2005). 
Electroporation 
Electroporation is the process of applying electrical field to a 
living cell for only microsecond or millisecond, 
approximately 100–1000 V/cm. This electrical field causes a 
transient reversible breakdown of the cellular membrane. 
This results in the formation of pores which allow delivery of 
drug to the cell.  Electroporation occurs when an applied 
external field exceeds the capacity of the cell membrane. It is 
proposed that water enters the cell membrane during the 
dielectric break down and that transient hydrophilic pores 
are formed. When such defects form, both low and high 
molecular weight compounds can be made to rapidly 
permeate through the skin. The formation of permeable 
areas happens in the frame in less than a second whereas 
resealing happens over minutes. The pores created by 
electroporation can also serve as additional transport 
pathways during Iontophoresis (William, et.al., 2004). 
Anionic lipids have been shown to greatly enhance the 
permeation of both small and large molecules .Under 
electroporation conditions. This effect was both charge and 
size dependent. Transport enhancement for molecules 
smaller than 1,000 Da occurred irrespective of their net 
charge, while in the case of large molecules (4,000–10,000 
Da) enhancement was observed only for negatively charged 
ions. (Bozena, 2005)  
Effects of Skin Hydration 
Hydration of the sc is among the most important factors in 
skin penetration, increasing the rate of passage of all 
substances that penetrate the skin. Hydration results from 
water diffusing from underlying epidermal layers or from 
perspiration accumulating after application of an occlusive 
vehicle or covering on the surface. Under occlusive 
conditions, the sc is changed from a tissue that normally 
contains very little water (5-15%) to one that may contain as 
much as 50% water. Permeability increases four to five fold. 
(Kligman, 2000).Hydration apparently “opens” the compact 
substance of the sc. (Krame and Wurster,1961)  measured 
the rate of penetration of esters of salicylic acid through skin 
with dry and hydrated sc. When the tissue was hydrated, the 
rate of penetration of the most water soluble ester increased 
more than that of the other esters studied. Further evidence 
of the importance of hydration can be found in 
investigations employing occlusive plastic films in steroid 
therapy. Here the prevention of water loss from the sc and 
the subsequent increased water concentration in this skin 
layer apparently enhance the penetration of the steroid  
(Smith 1962). 
Super Saturation of Drug 
Drug delivery can be optimized by using saturated solutions 
or suspensions of drugs. Supersaturated systems have been 
prepared by three techniques heating and cooling, use of 
cosolvent mixtures in which the drug has a very low 
solubility in one component. (William, et.al., 2004). and 
solvent evaporation methods employing a range of volatile 
and nonvolatile solvent mixtures. Unfortunately, 
supersaturated formulations commonly exhibit instability 
and both drugs and salts may precipitate out during 
manufacturing, storage or application. Stability of such 
supersaturated systems can be promoted by incorporating 
polymers that act as antinucleant crystal growth inhibitors 
such as hydroxpropyl methylcellulose (HPMC) and methyl- 
cellulose (MC).By adjusting concentrations of the 
antinucleant crystal growth inhibitors and supersaturation 
levels, can modulate the crystallization process and enhance 
topical delivery (Raghavan, et al., 2000).  
Improvement of Therapeutic Index 
The therapeutic index is a parameter that indicates the 
relative efficacy of a compound to its relative toxicity at 
various concentrations. It is calculated by dividing the toxic 
dose by the therapeutic dose .This parameter is an 
important measure of the relative safety of an active being 
used for a particular treatment. The use of the Therapeutic 
Index is well known in pharmaceutical practice and is 
growing for the evaluation of active compounds used in 
cosmetics. (i.e.“Cosmeceuticals”). Examples of such 
compounds include: alpha hydroxy acids, ceramides, and 
hyaluronic acid.  (Fesq, et al., 2003). The release rate of an 
active compound from a delivery system can affect the skin’s 
reaction to the compound. It can be generally stated that 
sustained release is recommended for actives that tend to 
irritate the skin, are applied at significantly high doses, or 
demonstrate rapid skin penetration. By extending the 
exposure time and reducing the amount released per unit of 
time, not only is effectiveness increased, but the reduced 
release rate allows the skin periods that enable it to adjust 
and, there by improve its ability to tolerate the new 
conditions. (Nguyen,  2003). 
DESIGN OF DELIVERY SYSTEM 
DELIVERY SYSTEM 
A delivery system is simply a way of holding, carrying, and 
transporting an active to a substrate. A delivery system can 
control the rate of release from a formulation as well as the 
rate of active absorption. It can minimize the concentration 
of active in the epidermis and dermis and there by minimize 
the potential for irritation. It can also maximize the 
concentration of active in a part of the substrate a concept 
known as the “Reservoir” effect delivery system is any type 
of vehicle that makes an “active” available to a target site. An 
effective delivery system is one that reaches the target and 
creates a high concentration reservoir for the active. 
Delivery systems may provide sustained release, controlled 
release, or release, without release into the substrate 
(Kasting, et.al.1987) 
They concentrate the payload. The bulk concentration is low 
but the concentrated material is delivered to the intended 
site. Delivery systems can be liquid/liquid systems such as 
oil-in-water or water-in-oil emulsions, micro emulsions, or 
multiple emulsions. Some delivery systems allow the 
incorporation of oil soluble actives in water based 
formulations while others enable the incorporation of water 
soluble actives in oil-based systems .Other forms of delivery 
systems include liquid/solid systems such as dispersions of 
inorganic materials like zinc oxide and titanium dioxide for 
sun screens. They can also be solid/solid systems such as 
freeze-dried Liposomes, or be actives encapsulated in 
molecular or macromolecular matrices to provide a dry 
powder form (Nguyen, 2003).  
 IDEAL CHARACTERISTICS OF DELIVERY SYSTEM 
The ideal delivery system would be non toxic to skin or hair, 
It would carry the actives into the substrate, provide 
controlled release (if desired), penetrate deeply or 
superficially (as needed), should be small enough to 
penetrate and be similar in polarity to target permeation 
paths of the skin (Meye, 2005). 
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DELIVERY SYSTEM FACTORS 
Delivery System Factors clearly, transdermal absorption of 
actives into the sc is a complex process and the design of 
transdermal formulations remains highly challenging. Such 
systems must not only maintain the stability of the active 
drug, but also insure that it will be released at a sufficient 
quantity and rate into the target tissue. Therapeutic moieties 
have to travel through the barriers and deliver into the 
systemic (Chapman, et al.,2002). Not all drugs are suitable 
for topical delivery. The low permeability of the skin limits 
the choice of candidates to those of high potency (usually 
<10 mg/day) and low molecular weight. Other 
considerations such as skin metabolism and the involvement 
of the immune system further limit the available drug 
choices.  
The permeability of a drug through the skin depends not 
only on the properties of the therapeutic moiety itself but 
upon various formulation factors. Examples of these include 
compatibility and irritancy or factors related to skin 
metabolism as well as inter-site, or inter-subject variability 
in skin permeability. The penetration of the active agent also 
depends upon the type of delivery system (Schmidt, 1989). 
Molecular Weight of the Drug Molecule 
Due to the presence of rigid corneocytes and intercellular 
lipids in the sc, the diffusion process is complicated. 
Molecular permeation through this structure can be 
described by the free volume theory where diffusion occurs 
by the dynamic exchange of molecules within free volume 
regions contained within the membrane (Lieb and Stein, 
1986) The equation describing this behavior can be 
expressed as the following eq. 
               Eq.2. D = D0 exp (−βMV) 
Where, β is a constant and D0 is the diffusivity of a 
hypothetical molecule exhibiting zero molecular volume. 
This exponential dependence of solute diffusivity on 
molecular volume has a great impact in terms of the 
predictability of mathematical models in describing skin 
permeation ( Kasting, et.al.,1987).As a rule of thumb, the 
maximum cutaneous flux of a permeant   decreases by a 
factor of five for every 100 Da increase in molecular weight. 
Furthermore, it has been observed that molecules exhibiting 
a molecular weight greater than 500 Da will generally not 
absorb through the skin. However, novel approaches to 
transdermal drug delivery such as the electrically assisted 
technologies have upwardly shifted the 500 Da limit towards 
a cut off in the 5,000 to 10,000 Da range (Berner and Cooper, 
1987). 
 Lipophilicity of the Active Molecule 
The Lipophilic nature of the sc and the aqueous nature of the 
underlying tissue indicate that the diffusant has to possess 
an optimal balance between lipophilic and hydrophilic 
properties. Generally, the skin is most permeable to 
moderately lipophilic compounds. Molecules that are more 
lipophilic will tend to become entrapped within the sc and 
not partition into the viable epidermis. Hence, quantitative 
structure permeability equations used to describe passive 
diffusion controlled penetration incorporate molecular 
weight (or molecular volume) and lipophilicity as the main 
determinants of transdermal absorption (Moser K, 2001). 
Effect of the Delivery System on Permeation 
The delivery system contains not only the active drug but 
also contains other formulation components such as 
penetration enhancers, stabilizers, and preservatives. All of 
these functional molecules are necessary for achieving 
successful drug or active delivery. The physical form of the 
delivery system/carrier/vehicle is crucial to the absorption 
process. These systems range from very small nano size 
particles or dispersions to emulsions of both the o/w type 
and w/o type, as well as lipid lamellar gels and the many 
other variations. The first step in transdermal absorption is 
the release and partitioning of the active agent from the 
delivery system into the sc. (Michniak, et.al.,2005). 
 A process governed by the drug or active’s partition 
coefficient. A vehicle should be carefully selected so that it 
has a high active-holding capacity but, at the same time; it 
does not suppress transport from the vehicle into the sc. The 
thermodynamic activities of the active molecule will 
continuously change in a volatile vehicle that undergoes 
evaporation. Moreover, the vehicle may itself absorb into the 
skin, and there can be variations in the degree of absorption 
depending upon which part of the body is involved. If the 
drug or active has a high affinity for the vehicle, it will be 
carried along as the solvent in the vehicle permeates into the 
tissue (Moser K, 2001). An absorbed vehicle may also change 
the partitioning of the drug or active from the formulation 
into the skin. Additionally, occlusive vehicles can hydrate the 
skin thus enhancing its permeability to a hydrophilic drug or 
active. Many studies have documented a synergistic effect 
exerted by some vehicles on the activity of penetration 
enhancers. Examples of this type of interaction include 
Azone-propylene glycol and fatty acids-propylene glycol 
(Venkatesan, et al  2009). 
RATIONALE REQUIRED FOR THE DEVELOPMENT 
OF A DELIVERY SYSTEM 
The fundamental reasons for the development of a delivery 
system are to improve penetration of actives and increase its 
stability. Table 1 shows the rationale involved in the 
development of a delivery system and based upon this there 
are some examples of delivery system designed for topical 
delivery of drugs. 
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Table1. Rationale Required for the Development of a Delivery System 
 
EXAMPLES OF DELIVERY SYSTEMS 
MICROENCAPSULE 
Microcapsules are produced by microencapsulation 
technique. Microencapsulation is the coating of small solid 
particles, liquid droplets or gas bubbles with a thin film of 
coating or shell material ( John and Sons 2005)  with the 
purpose to enable controlled release of the encapsulated 
material.In microcapsule applications where mechanical 
rupture is the controlled release mechanism .Topical 
preparation are encapsulated to reduce volatility  and 
sustained release.  There are three possible capsules 
structures Parameters used to characterize microcapsules 
include particle size, size distribution, geometry, actives 
content, storage stability, and core  material release rate( 
John W. 2005).  Figure 5 shows the different possible 
capsules based upon the core and coating material employed
 
.  
Figure5. Schematic diagrams of several possible capsules (a)continuous core/shell microcapsule(b)multi nuclear 
microcapsules(C) continuous core capsule with two different shells 
 
Microcapsule Release Mechanisms  
A variety of release mechanisms have been proposed for 
microcapsules. The structure and components of the capsule 
wall determine the release mechanism of the encapsulated 
active compound. There are four typical mechanisms by 
which the core material is released from a microcapsule 
these are mechanical rupture of the wall, melting of the wall, 
dissolution of the wall and diffusion through the wall ( 
Venkatesan P.et.al.2009) 
Mechanical Rupture 
In microcapsule applications, mechanical rupture is the 
controlled release mechanism. Release of the core material is 
either by applying direct pressure or abrasion during the 
application of the formulation to the skin. Rupture strength 
is inversely proportional to the size of the capsule. Figure 
6.shows that a compressive force breaks open the capsule by 
mechanical means.  
 
 
The wall is dissolved away from around the core such as 
when a liquid flavoring oil is used in a dry powdered 
beverage mix. The wall melts away from the core releasing 
the core in an environment such as that occurring during 
baking.The core diffuses through the wall at a slow rate due 
to the influence of an exterior fluid such as water or by an 
elevated temperature (Schugens, 1994) 
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Figure 7.Release mechanism 
 
Controlled Release  
The controlled release of material from capsules is deliver 
the drug in controlled manner .The   capsules serve as 
vehicles to deliver beneﬁcial agents . In the controlled 
release system, biodegradable microcapsules are one of the 
most useful devices to deliver materials in an effective, 
prolonged and safe manner (Fassihit, et.al., 2004).Drugs 
which formulated in controlled release dosage forms in 
polymeric devices are released either by diffusion through 
the polymer barrier, or by erosion of the polymer material, 
or by a combination of both diffusion and erosion 
mechanisms (William, et.al.2006). 
Encapsulation by In Situ Polymerization 
Different microencapsulation techniques have been used to 
control drug release form topical delivery systems (Rasool, 
et.al., 2003). In situ polymerization is one type of 
encapsulation techniques, it is a chemical formulation by 
supplying monomer from either inside or outside of the core 
material and polymerizing it on the surface of the core 
material (Schugens, 1994).  This process is ideal for 
protecting hydrophobic materials and involves the 
deposition of a polymeric material at the solid/liquid 
interface. In situ polymerization is a process in which the 
capsule shell is formed by the polymerization of monomers 
added to the encapsulation reactor .In this process, 
polymerization occurs exclusively in the continuous phase 
and at the interface formed by the dispersed core material 
and the continuous phase. Polymerization of reactants 
located in the continuous phase produce a low molecular 
weight pre polymer. As this pre polymer grows in size, it 
deposits onto the surface of the dispersed core material. 
Continued polymerization, with cross-linking, continues to 
generate a solid capsule shell (Matsen, et.al.,1970). 
VESICULAR  
Vesicular systems are one of the most controversial methods 
for transdermal delivery of active substances.(Gupta, et.al., 
2012) Depending upon their  composition and physical 
properties, vesicles can either serve as a compound’s 
carriers,   skin permeation enhancers, or as a vehicle base 
which provides a reservoir. Such a reservoir can be created 
in the sc, epidermis, or even in the hair follicles and 
sebaceousglands (Verma, et.al. 2003)  
LIPOSOME  
Liposomes are microscopic vesicles composed of one or 
more lipid bilayers (Egbaria  and Weiner, 1990).Which are 
used as carriers for drugs and delivers actives through the 
skin. Liposomes can direct a drug to a certain target. It can 
also prolong the duration of drug exposure, acting as a slow 
release reservoir Liposomes can protect a drug against 
degradation (for example metabolic degradation). Liposomes 
might be useful for increased local activity while diminishing 
the Percutaneous absorption of the drug. The mechanism by 
which liposomal vesicles deliver actives is not fully 
understood. It is believed that variations in vesicle 
properties can influence rate and degree of penetration and 
thereby produce a range of delivery profiles. (Kadir, 
et.al.,1999). 
The applicability of liposomal hydrocortisone as a selective 
drug delivery system for cutaneous administration of 
glucocorticoids has been studied by Wohlrab and Lasch 
(Wohlrab, and Lasch, 1987). Topical application of a 
liposomal preparation of hydrocortisone resulted in higher 
concentrations of drug in the individual layers of human skin 
as compared to a similar application of hydrocortisone 
formulated as an ointment. (Liposomes can be loaded with 
different hydrophilic, lipophilic, or amphiphilic actives 
including vitamins (Egbaria  and Weiner, 1990). 
LIPOSOME GEL 
Liposome gel are formed in the presence of intelligent 
polymers. It was expected that the stabilization approach of a 
single vesicle illustrated in (Fig. 8) could be modified into a 
polymer-mediated stabilization process in the presence 
hydrophobically modified water soluble polymers .In this 
case, where the length of the water-soluble part of the 
polymer (PEG as an example) exceeds the average distance 
between two vesicles (in a vesicle dispersion), a bridge is 
easily formed. The hydrophobic ends of the polymer (for 
example, stearic acid or cholesterol) have a strong tendency 
to insert into the bilayer membrane of the liposomes by a self 
organization process (Fig. 9).  
In a way, the polymers are expected to behave intelligently 
because they build up a more complex nanoscale structure 
without the assistance of the formulator. This network is 
transient because the polymer end groups are able to leave 
the bilayer membrane. However, this is an unlikely process, 
because the hydrophobic end groups of the polymer tend to 
minimize their contact with water. Further, addition of such 
polymer molecules leads to a three-dimensional network of 
connected liposomes (Wolfgang  and Jörg, 2005). 
 
Figure 8. Stabilization of a single vesicle by a hydrophobically 
modified water soluble  polymer. 
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Figure 9.Crosslinkingof two liposomes by 
A hydrophobically modified water soluble polymer 
 
Figure 10.Gel formation by crosslinking of several liposomes 
with ahydrophobically modified   water soluble polymer 
Mezei et al. (Mezei, and Gulasekharam, 1982b) compared the 
deposition of topically applied gels of free and liposomally 
entrapped triamcinolone in rabbit skin. They found that 
application of the liposomal gel resulted in a concentration of 
triamcinolone acetonide approximately five times higher in 
the epidermis and three times higher in the dermis, than 
application of the free drug gel. The results of this study 
(Mezei, and Gulasekharam, 1980a) suggested to them the 
inherent potential of liposomes as a selective drug delivery 
system for cutaneous application.  
ELASTIC VESICLES  
Elastic vesicles have been designed to facilitate the delivery 
of active compounds to and through the skin. It enhances 
skin permeation by deformable “fluid” nature of the vesicles 
and   it carries the active in to deeper layers of the skin. By 
this means, the lag time for penetration and the amount of 
active compound that penetrates is significantly decreased 
and increase respectively (Trotta, et.al.,2004).  
Examples of Elastic Vesicle 
Ethosomes  
Ethosomes are soft, lipid vesicles containing phospholipids, 
alcohol and water. It is novel carrier system used for delivery 
of drugs having low penetration through the biological 
membrane mainly skin. Ethosomes permeate through the 
skin layers more rapidly than liposome. 
The mechanism of Ethosomes for better permeation is still 
not clear. But the synergistic effects of combination of 
phospholipids and ethanol in vesicular formulations have 
been suggested to be responsible for deeper distribution and 
penetration in the skin lipid bi-layers.  
Ethanol acts as a penetration enhancer by increasing the 
fluidity of cell membrane lipids and decrease the density of 
lipid bilayer of cell membrane so the Ethosomes can 
permeate   easily inside the deep skin layers   and releases 
the drugs into deep layer of skin (Gupta, et. al.2012).
 
 
Firure11.Diagrammatical  representation of mechanism of action of ethosomes. 
PARTICULATE SYSTEMS 
Particulate systems can be designed to specifically target 
follicular structures based on particle diameter and vehicle 
composition. The particulate delivery systems used in 
topical formulations include: Porous polymeric systems, 
Microparticulates, Nanoparticulates 
Porous Polymeric Systems 
Porous polymeric particles with high internal surface area 
like cellulose are used to entrap active compounds and serve 
as delivery systems. The active compound is released from 
the particle by means of simple diffusion (Lieb, 1992).The 
spheres can be programmed to release the entrapped active 
ingredient to the skin in a controlled time release pattern or 
a pre-programmed manner through the use of several 
different triggers such as rubbing or pressing the system 
after it has been applied to the skin, elevating the skin 
surface temperature, introducing solvents such as water, 
alcohol, perspiration for the entrapped material.  
Entrapment systems can control the release of actives onto 
the epidermis with assurance that the actives remain 
primarily localized and do not enter the systemic circulation 
in significant amounts, thus reducing toxicity while 
maintaining efficacy (Patravale and Mandawgade, 2008).` 
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Microparticulates 
Micro particles are solid polymeric particles falling in the 
range of 0.1–1000 µm and include microcapsules and 
microspheres. Micro particles are used in cosmetics to avoid 
incompatibility of substance, reduce odour of actives and for 
protection of substances prone to oxidation or action by 
atmospheric moisture. 
Porous Microparticles 
Porous polymeric particles with high internal surface area 
are used to entrap active compounds and serve as delivery 
systems. These materials can be incorporated into gels, 
creams, liquids, or powders. They can be synthetic in origin, 
such as polyacrylates, polymethacrylates and polyamides. 
Since these porous particulates are “open” systems,the 
entrapped active compound is released from the particle by 
means of simple diffusion.Key physical properties of these 
particles include (Schott,2000). 
• Particle density (g/cm3), mass per volume 
• Total specific surface area of pores (m2/g) 
• Average pore diameter (μm) 
• Oil absorption capacity (ml/100g) 
• Particle average size (nm or μm) and size distribution 
• Zeta potential (mV) 
Zeta potential can be a significant and useful tool for 
predicting and controlling the stability of colloidal 
suspensions or emulsions. When the absolute value of the 
zeta potential is above 50 mV, the dispersion has better 
likelihood of being stable due to mutual electrostatic 
repulsion of the particles. 
When the zeta potential is close to zero, interparticle 
coagulation, the formation of large particle assemblies, can 
be rapid and cause sedimentation   or creaming depending 
on the relative density of the particles and the external 
phase. Different external phase conditions can also affect the 
zeta potential. These include salt concentration, pH, and 
surfactant concentration (Lieb,  1992). 
NANOPARTICULATE SYSTEMS 
Nanoparticles for Topical Delivery Of Drugs 
Nanoparticle   defined as single particles with a diameter 
under 100 nm.  Due to their small size, it can pass through 
biological barriers easily and serve as delivery systems for 
topical formulations. With potential nanoparticle 
distribution sites that include the surface of the skin and hair 
follicles (Prow, et.al.,1998). Nanoparticle also used as 
carriers for sun screens  to prolong residence time in the sc, 
and to target vitamin A to the upper layers of skin. The 
particle size and composition of nanoparticle are influence 
the interactions between particle and skin and the rate and 
extent with which it releases an incorporated ‘active’ 
ingredient into the sc (Landfeste, et.al.,2010). 
Poly (lactide-co-glycolide) has been used as a polymer for 
creation of matrix-type nanoparticles used to entrap the 
antiviral drugs cidofovir, and acyclovir. When applied to the 
skin and compared to polyvinyl alcohol solution, the 
particles significantly increased drug retention in the 
epidermis and decreased permeation through the skin 
(Blanco, 2002).  
 Figure 12, describes different Sites in skin for nanoparticle 
delivery. Topical nanoparticle drug delivery takes   place in 
three major sites, these are sc, dermal-epidermal junction 
and blood vessels.  
 
 
Fig.12.Stratum corneum (SC) surface (panel a), furrows 
(dermatoglyphs) (panel b), and openings of hair follicles 
(infundibulum) (c). The nanoparticles are shown in green 
and the drug in red. Other sites for delivery are the viable 
epidermis (E) and dermis (D). 
SOLID LIPID NANOPARTICLES AND NANO-
STRUCTURED LIPID CARRIERS 
Solid lipid nanoparticles and nanostructured lipid carriers 
are novel drug delivery complexes with many cosmetic and 
dermatological applications.Their attributes include, 
increased absorption, enhanced penetration and control 
release properties. The sc of the skin prevents the 
penetration of hydrophilic compounds more efficiently than 
of lipophilic ones, thus lipid based carriers may be used to 
transport hydrophilic drugs (Moser, 2001). 
A multitude of cosmetic ingredients have been incorporated 
into various lipid particles, SLNs have shown efficacy when 
utilized to treat eczema and acne, as UV absorbers in sun 
blocks, and as carriers of moisturizers. (Hoffman, 1998)   
A NOVEL APPROACH FOR TRANSDERMAL DRUG 
DELIVERY  
TRANSFEROSOMES 
 Transferosomes are self aggregates, with an ultra flexible 
membrane which delivers the drug reproducibly into or 
through the skin. Transferosomes, when applied under 
suitable condition, can transfer 0.1 mg of lipid per hour and 
square centimeter area across the intact skin. This value is 
substantially higher than that typically driven by the 
transdermal concentration gradients. The reason for this 
high flux rate is naturally occurring "transdermal osmotic 
gradients.Transferosomes overcome the skin penetration 
difficulty by squeezing themselves along the intracellular 
sealing lipids of the sc. (Jain, 2003). These vesicles have been 
seen to improve the therapeutic index of topically applied 
glucocorticosteroids. Elastic vesicles have also been found to 
perform better than rigid vesicles or traditional micelles in 
promoting the transdermal delivery of the receptor agonist 
rotigotine that is being used to treat parkinson’s disease. 
Studies on the elastic vesicles were shown to act as the 
molecule’s carrier and not solely act in the role of 
penetration enhancers. Flexible vesicles have been found to 
interact differently with the skin when compared to rigid 
vesicles. While no ultrastructural changes were observed in 
rigid vesicle (Honeywell, 2003). 
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MOLECULAR SYSTEM –DENDRIMERS 
Dendrimers are three dimensional, large manmade 
macromolecules with a branched structure. They can act as a 
“molecular micelle” to entrap other molecules (Mandawgade  
and Patravale, 2008). Dendrimers typically consist of a core 
that is usually composed of an amine, or of sugar molecules, 
and consist of alternating layers of two monomers. Different 
types of Dendrimers have been shown to enhance the 
transdermal delivery of indomethacin, an anti-inflammatory 
drug.  Dendrimers have been used as delivery systems for 
topical application  of NSAIDs, and chemotherapeutics or 
antineoplastics.(Wang, et.al.,2003) 
 ECHODERM BASED TOPICAL FORMULATIONS 
(Anuska's, 2005) new products use Advanced Delivery 
System,the next generation of potent penetration after the 
liposome. (Echoderm™) expedites the process of Cellulite 
reduction by activating the natural skin structure in a body. 
This allows for optimized penetration and anchors the active 
ingredients between the layers of the skin allowing for 
prolonged release. Echoderm  helps in two ways  it reduce 
the growth of agents that are responsible for creating excess 
fat and stimulates anti-cellulite enzymes in the body 
MICRO SPONGE  
Microsponges are polymeric microspheres, with a very 
porous surface and are used mostly for topical 
administration. Microsponges are efficacious APIs delivery 
systems using a minimum dose and stability enhancers, it 
modify drug release and reduce side effects. Microsponge 
delivery systems (MDSs) consist of macroporous beads, with 
diameter size ranging between10 and 25 microns. The MDS 
are loaded with active agents which are released. The rate of 
active ingredients release of is depends on the partition 
coefficient of the active ingredient between the polymer and 
the vehicle or the skin, and also on some of the parameters 
that characterize the beads as surface area and mean pore 
diameter. Release can also be controlled through diffusion or 
other triggers such as moisture, pH, friction, or temperature 
(Sharon.et.al.,2012). 
 
Figure 13.Shows that incorporation of actives into 
microsponge 
CUBOSOMES 
Cubosomes are submicron, nanostructured particles of 
bicontinuous cubic liquid crystalline phase.  Cubosomes 
possess the same microstructure as the parent cubic phase 
but have much larger specific surface area with much lower 
viscosity than the bulk cubic phase.  The relative insolubility 
of cubic phase-forming lipid in water allows cubosomes to 
exist at almost any dilution level, as opposed to most liquid 
crystalline systems that transform into micelles at higher 
levels of dilution.  As a result, cubosomes can be easily 
incorporated into product formulations and serve as 
vehicles for drug delivery .  
Cubosomes are typically produced by high-energy 
dispersion of bulk cubic phase followed by colloidal 
stabilization using polymeric surfactants (Landh, 1994).  
After formation of the cubosomes, the dispersion is 
formulated into a product and then applied to a substrate of 
interest, usually bodily tissue. Thereafter materials are 
either absorbed or released via diffusion. 
 
Figure 14. Photographs of spray-dried powder precursors of 
cubosomes 
CHRONOSPHERES  
Chronospheres were developed in the pharmaceutical and 
medical device industry. Originally, Chronosphere-type 
products had their origins as flexible sheets called Chrono 
Flex was derived from  the reaction of a polyether with a 
difunctional isocyanate to form a polyurethane prepolymer. 
The polyurethane prepolymer was then reacted with a poly 
alcohol to form the flexible polyurethane sheet. The flexible 
polyurethanes, often referred to as polyurethane elastomers, 
have found unique medical applications in transdermal drug 
delivery and medical foams. Patents for the use of 
polyurethane foams as topical antifungal delivery devices 
were issued to Hydromer in 1988, PolyMedica introduced a 
pulverized powdered version of the ChronoFlex technology 
that they called Chronospheres. Polymedica had to modify 
the normal polyurethane elastomer technology so that more 
brittle polyurethanes could be made and they could be 
pulverized into powders. Chronospheres are unique, 
biocompatible, temperature-stable polymeric matrices into 
which useful active  ingredients can be added. Inside the 
polymeric matrix, the actives are essentially protected from 
external threats such as oxygen and moisture (James, 
et.al.,2005). 
OTHER FACTORS DETERMINING THE EFFICIENCY 
OF TOPICAL DRUG DELIVERY 
Determination of Site of Action 
Delivery systems for skin applications are designed to target 
the active compound into different sites of the tissue. These 
systems can be employed to retain the active on the surface 
of the skin, allow different partitioning patterns in the 
epidermis and dermis, and enhance the permeation of the 
active through the skin in order to provide transdermal 
delivery into the circulation. Determining the site of action 
and understanding the limitations of each of the approaches 
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described are critical to successful product development of a 
selected active. In today’s demanding environment, just 
targeting the sub tissue for delivery may be insufficient for 
achieving all of formulations desired goals. If, for example, 
the target for the active is an intracellular enzyme, the cell 
membrane barrier should also be taken into consideration 
since the active has to cross the barrier (Nava, 2005). 
 Intracellular Delivery 
Several in vitro experiments demonstrate inter-cellular 
penetration and effects on organelles and molecules that are 
located within the cell. While these results may be 
impressive, it is almost impossible to find a correlation 
between in vitro and in vivo activities. A few possible 
reasons for this include metabolism of the active component, 
its instability, penetration limitations, and differences in 
concentration. Further, when a “foreign” compound is 
applied to the skin and penetrates the sc, it may be identified 
as a “non self.” As a result, the “foreign” compound is most 
likely to generate an immune system response. This 
response may alter the skin condition (i.e., create skin 
inflammation), change the penetration profile, and thereby 
affect the therapeutic index. In this system, the physical 
proper-ties of the delivery system were of high importance. 
Since cell membranes are negatively charged, cat-ionic lipid 
vesicles enhanced intracellular penetration in comparison to 
uncharged vesicles (Dayan, and Touitou, 2000). 
Metabolism in Epidermis 
The outer layer of the skin considered to be almost inert. As 
the skin is the outer most layer of the body, is highly 
sensitive to interaction with outside stimuli. Examples of 
such stimuli include physical pressure, contact with 
chemicals, and temperature change. Environmental, as well 
as intrinsic factors (such as aging or a disease), may alter sc 
function and structure, thereby affecting the skin’s reaction. 
When developing a delivery system for skin, the metabolic 
changes of both the active as well as the delivery system 
components should be conceder. The epidermis is not 
simply a passive membrane that either blocks or permits 
entry of a drug. The skin, rich in enzymes, is the largest drug 
metabolizing tissue in the body. If the active is in a form of a 
“proactive”, metabolic changes are important to convert in 
to its active form (Nava, 2005).There are multifaceted 
relationships between epidermal cell production and 
development, differentiation of keratinocytes to 
corneocytes, corneocytes maturation, and desquamation. 
The natural path of living keratinocytes is losing their 
nucleus, dying, and being filled with keratin during 
migration from the stratum granulosum to sc on their way to 
becoming corneocytes. This process is a dynamic cascade 
that is controlled by enzymatic reactions acting in different 
time frames and affected by environmental factors. It is this 
process that will eventually determine the barrier properties 
of the skin (Bielinska, et.al.,2000). 
EXAMPLES OF TOPICAL APPLICATIONS  
Reduction of Melanin Synthesis by Tyrosinase Enzyme 
Melanin is the coloring agent of the skin. It synthesized in 
the melanocytes, the process of melanin generation is 
catalyzed by the enzyme tyrosinase one of the common 
approach to reducing skin pigmentation is limit melanin 
production by inhibiting activity of the enzyme tyrosinase. 
Melanosomes are specialized spherical shaped organelles 
that are the site of melanin synthesis and storage. In order to 
inhibit the tyrosinase enzyme, anti tyrosinase compounds 
have to penetrate the SC, reach the living epidermis, and 
permeate through the outer cell membranes of both the 
melanocytes and the melanosomes. The active compound or 
its delivery system must, therefore, possess cell membrane-
permeating properties. (Nordlund , and Boissy,  2000). 
Ferulic acid is one of tyrosinase enzyme inhibitor. It is also 
anti-oxidant and photo protective, topical formulation of 
vitamin C and vitamin E with ferulic acid is more effective 
and it reduces irritation and increase stability (Nava 2005). 
Improvements of Skin Condition and Intrafollicular 
Delivery 
There are three basic ways to remove dead skin cells so, they 
don’t clog pores and kill the bacteria that cause 
inflammation. The pilosebaceous pathway is primary target 
of action to improve skin condition. A few specific delivery 
systems, including liposomes and synthetic microspheres, 
have been found to localize in follicular and sebaceous areas. 
This localization serves to provide a reservoir for active 
compounds. Liposomes have been shown to enhance 
follicular delivery of both small polar molecules as well as 
macromolecules. Androgen hormone penetrated the 
sebaceous glands more effectively from Liposomes than 
from an alcoholic solution (Bernard, et.al., 1997). Salicylic 
acid is an active compound used in topically applied 
formulations.  It acts as a keratolytic agent as well as having 
bactericidal and fungicidal properties. This organic acid has 
some drawbacks that limit its use. One of these limitations is 
its relative ease of absorption into the skin. This may lead, in 
some cases, to systemic toxicity, and, at the same time, result 
in reduced activity within its target of action i.e., the 
sebaceous gland within the living epidermis (Parfitt, 1999). 
A delivery system developed using polymeric, porous nylon 
particles containing an anhydrous solution of salicylic acid 
has been shown to create a reservoir of salicylic acid within 
the epidermis. This reservoir significantly reduces 
percutaneous absorption. Figure15 describes the flux of 
salicylic acid through the skin upon  Application of two 




Figure 15.Flux through the skin of free salicylic acid (SA) vs SA adsorbed in porous nylon paricles 
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During the first eight hours of the experiment, the free 
salicylic acid flux through the skin was significantly higher 
than the flux obtained with the delivery system containing 
adsorbed salicylic acid. Extraction of the skin at the end of 
the experiment showed a higher reservoir of salicylic acid in 
the epidermis occurred when using the adsorbed salicylic 
acid (Nava 2005)., 
Improving Superficial Delivery 
Some important ingredients used in topically applied 
formulations are intended to protect the skin or alter its 
appearance by only affecting its optical properties. Such 
compounds need to be formulated and incorporated into 
delivery systems so their penetration into the skin will be 
minimal. Examples of such products include sunscreens and 
optically activated compounds. Here as well, the design of 
the formulation and the delivery system plays a major role in 
the prevention of penetration and reduction of irritation as 
measured by changes in the therapeutic index. The presence 
or absence of appropriate protective ingredients in the 
formulation may prevent irritation.  An example of a delivery 
system developed to protect the active component and 
prevent its inter-action with the skin is a novel technology 
that combines fluorescence and light scattering. The product, 
called LipoLight™, exhibits an approach for the creation of a 
synergistic effect that results in a reduction of the perception 
of skin imperfections. This system is composed of a 
fluorescent molecule fixed to porous nylon particles and 
encapsulated in a translucent shell of cross-linked polyvinyl 
alcohol. When formulated properly into creams, lotions, or 
gels, these particles allow for a dramatic reduction in the 
appearance of skin imperfections (Sojka,2003). 
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